Literature DB >> 9308333

Leukoencephalopathy after inhalation of heroin vapor.

Y J Chang1, C H Tsai, C J Chen.   

Abstract

A 25-year-old man presented in March 1996 with progressive dysarthria, cerebellar ataxia, and dystonia, which began after he inhaled heroin vapor for a full day 2 months previously. The patient had a 2-year history of heroin inhalation. Magnetic brain stimulation showed waveform dysynchronization suggestive of motor pathway perturbation above the cervical spinal level. Brain computed tomography and magnetic resonance imaging revealed extensive symmetric white matter involvement of bilateral cerebral and cerebellar hemispheres and the brainstem, especially along the corticospinal tract. The clinical features, electrophysiologic manifestations, and imaging studies strongly indicated a lipophilic toxin-induced demyelinating process, mainly involving the central motor system, as the most likely cause of heroin leukoencephalopathy. This is the first reported case of heroin-related leukoencephalopathy in Taiwan.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9308333

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  3 in total

1.  Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR imaging and clinical features in three patients.

Authors:  Stella Blasel; Elke Hattingen; Michael Adelmann; Michael Nichtweiß; Friedhelm Zanella; Stefan Weidauer
Journal:  Clin Neuroradiol       Date:  2010-02-28       Impact factor: 3.649

2.  The molecular neurobiology and neuropathology of opioid use disorder.

Authors:  Christopher A Blackwood; Jean Lud Cadet
Journal:  Curr Res Neurobiol       Date:  2021-10-14

3.  Chasing the dragon - characterizing cases of leukoencephalopathy associated with heroin inhalation in British Columbia.

Authors:  Jane A Buxton; Renee Sebastian; Lorne Clearsky; Natalie Angus; Lena Shah; Marcus Lem; Sian D Spacey
Journal:  Harm Reduct J       Date:  2011-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.